Chinook investor relations
WebNoopur Liffick is Senior Vice President of Investor Relations and Corporate Communications at Chinook Therapeutics. With over 17 years of investor relations, … WebApr 15, 2024 · Chinook assumes no obligation to update forward-looking statements whether as a result of new information, future events or otherwise, after the date of this press release. Contact: Noopur Liffick Vice President, Investor Relations & Corporate Communications [email protected] [email protected] Source: Chinook …
Chinook investor relations
Did you know?
WebDec 1, 2024 · Chinook Therapeutics To Form SanReno Therapeutics. 50/50 joint venture with investor syndicate led by Frazier Healthcare Partners and Pivotal bioVenture Partners China. Expands global reach and execution for Chinook’s atrasentan and BION-1301 programs in IgA nephropathy (IgAN) SEATTLE , Nov. 30, 2024 (GLOBE NEWSWIRE) — … Web23 hours ago · Chinook assumes no obligation to update forward-looking statements whether as a result of new information, future events or otherwise, after the date of this press release. Contact: Noopur Liffick Senior Vice President, Investor Relations & Corporate Communications [email protected] [email protected]
WebMar 28, 2024 · The archived webcast will remain available for replay on Chinook’s website for 90 days. About Chinook Therapeutics, Inc. Chinook Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing precision medicines for kidney diseases. Chinook’s product candidates are being investigated in rare, severe chronic kidney … WebJan 31, 2024 · INVESTORS OVERVIEW. AN2 Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing treatments for rare, chronic, and serious infectious diseases with high unmet needs. Our initial product candidate is epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial, or NTM, lung …
WebFeb 27, 2024 · Chinook assumes no obligation to update forward-looking statements whether as a result of new information, future events or otherwise, after the date of this press release. Contact: Noopur Liffick WebMay 25, 2024 · SEATTLE, May 24, 2024 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (Nasdaq: KDNY) today announced the pricing of its underwritten public offering of …
Web2 days ago · SEATTLE, April 11, 2024 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company focused on the discovery, development …
WebChinook Therapeutics (Nasdaq: KDNY) is a clinical-stage biotechnology company developing precision medicines for kidney diseases. Chinook’s product candidates are being investigated in rare ... fishing rod funeral flowersWeb23 hours ago · Chinook assumes no obligation to update forward-looking statements whether as a result of new information, future events or otherwise, after the date of this … fishing rod for striped bassWebNov 4, 2024 · Chinook to host investor conference call and webcast today at 4:30 pm EDT with Jonathan Barratt, MChB, PhD, Mayer Professor of Renal Medicine at University of Leicester, and Laura Kooienga, MD ... cancel home purchase contractWebOct 5, 2024 · Prior Chinook stockholders collectively own approximately 39.5% of the combined company, prior Aduro stockholders collectively own approximately 39.9% of the combined company and investors in the ... fishing rod for steelheadWebNov 10, 2024 · Mr. Bjerkholt joins Chinook from Aimmune Therapeutics, Inc., where he most recently served as CFO overseeing financial reporting, budgeting, internal controls, investor relations, business ... fishing rod grips handlesWebApr 7, 2024 · SEATTLE, April 07, 2024 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company focused on the discovery, development and commercialization of precision medicines for kidney diseases, today announced that the Compensation Committee of the Company’s Board of Directors approved new … cancel honeybookWeb2 days ago · SEATTLE, April 11, 2024 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company focused on the discovery, development and commercialization of precision medicines for kidney diseases, today announced that Chinook management is scheduled to participate in the following upcoming investor … cancel honeybook subscription